Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Plant cell expressed recombinant glucocerebrosidase (prGCD)
DRUG
2 trials
Sponsors
Pfizer
Conditions
Gaucher Disease
Phase 3
A Phase III Trial to Assess the Safety and Efficacy of Plant Cell Expressed GCD in Patients With Gaucher Disease
Completed
NCT00376168
Pfizer
Gaucher Disease
Start: 2007-08-31
End: 2009-10-31
Updated: 2018-10-04
Unknown Phase
Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease
NCT00962260
Pfizer
Gaucher Disease
Updated: 2018-09-07
Related Papers
Open-Label, Expanded Access Study of Taliglucerase Alfa in Patients with Gaucher Disease Requiring Enzyme Replacement Therapy
Blood
2018-11-29
Long‐term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment‐naïve patients with Gaucher disease
American Journal of Hematology
2016-03-19
23 citations
Pharmacokinetics of Novel Plant Cell-Expressed Taliglucerase Alfa in Adult and Pediatric Patients with Gaucher Disease
PLoS ONE
2015-06-08
11 citations